Related Experiment Video
Updated: May 29, 2026

Controlled Reversible Visceral Arterial Ischemia, Venous Congestion and Combined Malperfusion via Midline Laparotomy in Rats
Published on: July 5, 2024
[Cardiovascular pathology associated with digestive system diseases]
Insights
Older adults often have multiple diseases, impacting cardiac drug effectiveness. Understanding gastrointestinal effects of heart medications is crucial for safe and effective treatment.
Area of Science:
- Cardiology
- Gastroenterology
- Pharmacology
Context:
- Aging populations experience a higher prevalence of multiple comorbidities.
- Ischemic heart disease (IHD) management in elderly patients requires consideration of co-existing conditions, particularly gastrointestinal (GI) disorders.
- GI diseases can alter the clinical course of IHD and affect cardiac drug pharmacokinetics.
Purpose:
- To highlight the complex interplay between cardiac medications and gastrointestinal health in elderly patients.
- To emphasize the need for a comprehensive approach to pharmacotherapy in patients with multiple chronic conditions.
Summary:
- Cardiac drugs, used for conditions like IHD, exhibit varied effects on the digestive system, both beneficial and detrimental.
- Positive effects include beta-blockers and nitrates for esophageal varices and calcium antagonists for achalasia.
- Negative effects involve aspirin-induced gastric ulcers and GERD exacerbation by calcium antagonists (dihydropyridines).
Impact:
- Informs clinical practice regarding rational pharmacotherapy for elderly patients with IHD and GI comorbidities.
- Promotes safer and more effective prescribing of cardiac medications by considering potential GI side effects.
- Underscores the importance of interdisciplinary care in managing complex geriatric patients.
Abstract:
With age, a person has "accumulation" of diseases. In patients of older age groups occurs simultaneously for at least 3-4 diseases. Assigning patients with ischemic heart disease (IHD), the physician takes into account the presence of concomitant diseases, especially diseases of the gastrointestinal tract, since the defeat of the stomach, liver, intestine may influence not only on the clinical course of heart disease, but also to change the pharmacokinetics of cardiac drugs. All groups of drugs used in treating coronary artery disease, have different effects on the digestive organs. This can be a positive influence. For example, the use of beta-blockers and nitrates for prevention of bleeding from esophageal varices at cirrhosis of the liver, calcium antagonists in achalasia cardia. It is well known, and the negative effect of cardiac drugs: erosive and ulcerative lesions of the stomach with aspirin use, increasing manifestations of GERD in patients receiving calcium antagonists (dihydropyridines group). In this regard, we need for rational pharmacotherapy.
Related Concept Videos
Other Disorders of Digestive System
Major Organs of the Digestive System
Gastrointestinal tract:
Blood Supply to the Digestive System
Blood Supply to the Digestive System: The splanchnic circulation involves three main arteries: the celiac artery (also known as the celiac trunk) and the superior and inferior mesenteric...
Chronic Bowel Disorders: Introduction
Irritable Bowel Syndrome (IBS) is a common disorder affecting the gastrointestinal tract. The distinctive feature is recurrent abdominal pain associated with altered bowel movements, manifesting as constipation, diarrhea, or fluctuating between both. The...
Portal Hypertension
Gastritis-II: Pathophysiology
In acute gastritis, the gastric mucosa becomes swollen and red and undergoes superficial erosion. Superficial ulceration may lead to bleeding.
In chronic gastritis, persistent or repeated insults lead to chronic inflammatory changes and, eventually, thinning or atrophy of the gastric tissue.
Gastritis can stem from various causes, each...